A potential drug interaction between liraglutide and clonazepam has been reported. This interaction may be related to the risk of depression, anxiety, and suicidal behavior in patients with obesity who are taking glucagon-like peptide-1 receptor agonist therapy. The specifics of the interaction and its effects are being studied, with a case report and scientific research contributing to the understanding of this issue.